New tentative approval for Sandoz Inc drug rifaximinBy DrugPatentWatch – Make Better Decisions / March 22, 2024 Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There are twenty-nine patents protecting this compound. Drug patent litigation for…Source